[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
作者信息
Tissot R, Gaillard J M, Guggisberg M, Gauthier G, De Ajuriaguerra J
出版信息
Neurol Neurocir Psiquiatr. 1969;10(1):1-25.
PMID:5406970
Abstract
摘要
相似文献
1
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
Neurol Neurocir Psiquiatr. 1969;10(1):1-25.
2
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Wien Med Wochenschr. 1971 Oct 16;121(42):741-5.
3
4
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
5
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
6
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].[联合用药（左旋多巴加脱羧酶抑制剂（Ro 8-0576））治疗帕金森病的经验]
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
7
[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Dtsch Med Wochenschr. 1969 Dec 26;94(52):2678-81. doi: 10.1055/s-0028-1110503.
8
[Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
Presse Med (1893). 1969 Apr 5;77(17):617-8.
9
10
Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.左旋多巴联合外周脱羧酶抑制用于帕金森病治疗
Can Med Assoc J. 1972 Jun 10;106(11):1169-74.
引用本文的文献
1
A review of studies on gut microbiota and levodopa metabolism.关于肠道微生物群与左旋多巴代谢的研究综述。
Front Neurol. 2023 Jun 2;14:1046910. doi: 10.3389/fneur.2023.1046910. eCollection 2023.
Zotero 插件